HCR Wealth Advisors Sells 2,747 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

by · The Cerbat Gem

HCR Wealth Advisors reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 10,706 shares of the financial services provider’s stock after selling 2,747 shares during the period. HCR Wealth Advisors’ holdings in iShares Biotechnology ETF were worth $1,559,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in IBB. Valeo Financial Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $206,000. Albion Financial Group UT lifted its stake in iShares Biotechnology ETF by 0.3% in the third quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock worth $18,925,000 after purchasing an additional 356 shares during the last quarter. Capital Insight Partners LLC boosted its position in iShares Biotechnology ETF by 5.4% during the third quarter. Capital Insight Partners LLC now owns 14,431 shares of the financial services provider’s stock valued at $2,101,000 after buying an additional 739 shares during the period. Connective Portfolio Management LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter valued at about $849,000. Finally, Royal Fund Management LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth about $1,304,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.7 %

IBB stock traded up $2.44 during trading on Friday, hitting $145.59. 2,178,921 shares of the company traded hands, compared to its average volume of 1,483,730. The company has a 50-day moving average of $145.12 and a 200-day moving average of $139.34. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).